Amelioration of sepsis by TIE2 activation-induced vascular protection

Science Translational Medicine

Volumn 8, Issue 335, 2016, Pages

  Han, Sangyeul ^a,b   Lee, Seung Jun ^b,c   Kim, Kyung Eun ^a,i   Lee, Hyo Seon ^a,i   Oh, Nuri ^c,j   Park, Inwon ^c   Ko, Eun ^a,i   Oh, Seung Ja ^a   Lee, Yoon Sook ^a,i   Kim, David ^c   Lee, Seungjoo ^c   Lee, Dae Hyun ^c   Lee, Kwang Hoon ^a,k   Chae, Su Young ^a,i   Lee, Jung Hoon ^a,i   Kim, Su Jin ^a,i   Kim, Hyung Chan ^a,i   Kim, Seokkyun ^a,i   Kim, Sung Hyun ^a,l   Kim, Chungho ^d   Nakaoka, Yoshikazu ^e   He, Yulong ^f   Augustin, Hellmut G ^g,h   Hu, Junhao ^g   Song, Paul H ^a   Kim, Yong In ^a,m   Kim, Pilhan ^c   Kim, Injune ^c   Koh, Gou Young ^b,c   more..

^a Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^b Institute for Basic Science   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d Korea University   (South Korea)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f SOOCHOW UNIVERSITY   (China)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ Samsung Bioepis Co Ltd   (South Korea)

^j SAMSUNG Electronics   (South Korea)

^k Osong Medical Innovation Foundation   (South Korea)

^l Korea Institute of Ceramic Engineering and Technology (KICET)   (South Korea)

^m Medytox   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2 BINDING AND TIE 2 ACTIVATING ANTIBODY; ANGIOPOIETIN RECEPTOR; ANTIBODY; UNCLASSIFIED DRUG; ANG2 PROTEIN, MOUSE; ANGIOPOIETIN 2; C11ORF2 PROTEIN, HUMAN; PANCREATIC RIBONUCLEASE; VESICULAR TRANSPORT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL PROTECTION; CONTROLLED STUDY; CYTOKINE STORM; GLYCOCALYX; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTECTION; PROTEIN PROTEIN INTERACTION; SEPSIS; SIGNAL TRANSDUCTION; VASCULARIZATION; ANGIOGENESIS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; HUMAN; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ANGIOPOIETIN-2; ANIMALS; ANTIBODIES; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHIL INFILTRATION; RECEPTOR, TIE-2; RIBONUCLEASE, PANCREATIC; SEPSIS; VESICULAR TRANSPORT PROTEINS;

EID: 84964490181     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad9260     Document Type: Article

References (70)

1. D. C. Angus, T. van der Poll, Severe sepsis and septic shock. N. Engl. J. Med. 369, 840-851 (2013).
2. N. K. J. Adhikari, R. A. Fowler, S. Bhagwanjee, G. D. Rubenfeld, Critical care and the global burden of critical illness in adults. Lancet 376, 1339-1346 (2010).
3. M. P. Fink, H. S. Warren, Strategies to improve drug development for sepsis. Nat. Rev. Drug Discov. 13, 741-758 (2014).
4. T. van der Poll, S. M. Opal, Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8, 32-43 (2008).
5. V. M. Ranieri, B. T. Thompson, P. S. Barie, J.-F. Dhainaut, I. S. Douglas, S. Finfer, B. Gårdlund, J. C. Marshall, A. Rhodes, A. Artigas, D. Payen, J. Tenhunen, H. R. Al-Khalidi, V. Thompson, J. Janes, W. L. Macias, B. Vangerow, M. D. Williams; PROWESS-SHOCK Study Group, Drotrecogin alfa (activated) in adults with septic shock. N. Engl. J. Med. 366, 2055-2064 (2012).
6. N. M. Goldenberg, B. E. Steinberg, A. S. Slutsky, W. L. Lee, Broken barriers: A new take on sepsis pathogenesis. Sci. Transl. Med. 3, 88ps25 (2011).
7. N. R. London, W. Zhu, F. A. Bozza, M. C. P. Smith, D. M. Greif, L. K. Sorensen, L. Chen, Y. Kaminoh, A. C. Chan, S. F. Passi, C. W. Day, D. L. Barnard, G. A. Zimmerman, M. A. Krasnow, D. Y. Li, Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med. 2, 23ra19 (2010).
8. S. M. Opal, T. van der Poll, Endothelial barrier dysfunction in septic shock. J. Intern. Med. 277, 277-293 (2014).
9. W. L. Lee, A. S. Slutsky, Sepsis and endothelial permeability. N. Engl. J. Med. 363, 689-691 (2010).
10. S. R. Coughlin, Thrombin signalling and protease-activated receptors. Nature 407, 258-264 (2000).
11. W. C. Aird, The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101, 3765-3777 (2003).
12. E. Lemichez, M. Lecuit, X. Nassif, S. Bourdoulous, Breaking the wall: Targeting of the endothelium by pathogenic bacteria. Nat. Rev. Microbiol. 8, 93-104 (2010).
13. N. P. J. Brindle, P. Saharinen, K. Alitalo, Signaling and functions of angiopoietin-1 in vascular protection. Circ. Res. 98, 1014-1023 (2006).
14. H. G. Augustin, G. Y. Koh, G. Thurston, K. Alitalo, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165-177 (2009).
15. S. David, C. C. Ghosh, P. Kümpers, N. Shushakova, P. Van Slyke, E. V. Khankin, S. A. Karumanchi, D. Dumont, S. M. Parikh, Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L851-L862 (2011).
16. T. Ziegler, J. Horstkotte, C. Schwab, V. Pfetsch, K. Weinmann, S. Dietzel, I. Rohwedder, R. Hinkel, L. Gross, S. Lee, J. Hu, O. Soehnlein, W. M. Franz, M. Sperandio, U. Pohl, M. Thomas, C. Weber, H. G. Augustin, R. Fässler, U. Deutsch, C. Kupatt, Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J. Clin. Invest. 123, 3436-3445 (2013).
17. B. Witzenbichler, D. Westermann, S. Knueppel, H.-P. Schultheiss, C. Tschope, Protective role of angiopoietin-1 in endotoxic shock. Circulation 111, 97-105 (2005).
18. S. David, J.-K. Park, M. van Meurs, J. G. Zijlstra, C. Koenecke, C. Schrimpf, N. Shushakova, F. Gueler, H. Haller, P. Kümpers, Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine 55, 251-259 (2011).
19. P. Kümpers, F. Gueler, S. David, P. Van Slyke, D. J. Dumont, J.-K. Park, C. L. Bockmeyer, S. M. Parikh, H. Pavenstädt, H. Haller, N. Shushakova, The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit. Care 15, R261 (2011).
20. S. M. Parikh, Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS. Virulence 4, 517-524 (2013).
21. C.-H. Cho, R. A. Kammerer, H. J. Lee, M. O. Steinmetz, Y. S. Ryu, S. H. Lee, K. Yasunaga, K.-T. Kim, I. Kim, H.-H. Choi, W. Kim, S. H. Kim, S. K. Park, G. M. Lee, G. Y. Koh, COMP-Ang1: A designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. U. S. A. 101, 5547-5552 (2004).
22. J. Lee, K. E. Kim, D.-K. Choi, J. Y. Jang, J.-J. Jung, H. Kiyonari, G. Shioi, W. Chang, T. Suda, N. Mochizuki, Y. Nakaoka, I. Komuro, O.-J. Yoo, G. Y. Koh, Angiopoietin-1 guides directional angiogenesis through integrin avb5 signaling for recovery of ischemic retinopathy. Sci. Transl. Med. 5, 203ra127 (2013).
23. C.-H. Cho, K. E. Kim, J. Byun, H.-S. Jang, D.-K. Kim, P. Baluk, F. Baffert, G. M. Lee, N. Mochizuki, J. Kim, B. H. Jeon, D. M. McDonald, G. Y. Koh, Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ. Res. 97, 86-94 (2005).
24. U. Fiedler, H. G. Augustin, Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol. 27, 552-558 (2006).
25. U. Fiedler, Y. Reiss, M. Scharpfenecker, V. Grunow, S. Koidl, G. Thurston, N. W. Gale, M. Witzenrath, S. Rosseau, N. Suttorp, A. Sobke, M. Herrmann, K. T. Preissner, P. Vajkoczy, H. G. Augustin, Angiopoietin-2 sensitizes endothelial cells to TNF-a and has a crucial role in the induction of inflammation. Nat. Med. 12, 235-239 (2006).
26. S. David, A. Mukherjee, C. C. Ghosh, M. Yano, E. V. Khankin, J. B. Wenger, S. A. Karumanchi, N. I. Shapiro, S. M. Parikh, Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis. Crit. Care Med. 40, 3034-3041 (2012).
27. S. M. Parikh, T. Mammoto, A. Schultz, H.-T. Yuan, D. Christiani, S. A. Karumanchi, V. P. Sukhatme, Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLOS Med. 3, e46 (2006).
28. J. M. Siner, V. Bhandari, K. M. Engle, J. A. Elias, M. D. Siegel, Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 31, 348-353 (2009).
29. T. Stiehl, K. Thamm, J. Kaufmann, U. Schaeper, T. Kirsch, H. Haller, A. Santel, C. C. Ghosh, S. M. Parikh, S. David, Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and death in sepsis. Crit. Care Med. 42, e654-e662 (2014).
30. J. Lomas-Neira, F. Venet, C.-S. Chung, R. Thakkar, D. Heffernan, A. Ayala, Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice. Am. J. Respir. Cell Mol. Biol. 50, 193-200 (2014).
31. J. L. Brown, Z. A. Cao, M. Pinzon-Ortiz, J. Kendrew, C. Reimer, S. Wen, J. Q. Zhou, M. Tabrizi, S. Emery, B. McDermott, L. Pablo, P. McCoon, V. Bedian, D. C. Blakey, A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. Mol. Cancer Ther. 9, 145-156 (2010).
32. C. C. Leow, K. Coffman, I. Inigo, S. Breen, M. Czapiga, S. Soukharev, N. Gingles, N. Peterson, C. Fazenbaker, R. Woods, B. Jallal, S.-A. Ricketts, T. Lavallee, S. Coats, Y. Chang, MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models. Int. J. Oncol. 40, 1321-1330 (2012).
33. J. Oliner, H. Min, J. Leal, D. Yu, S. Rao, E. You, X. Tang, H. Kim, S. Meyer, S. J. Han, N. Hawkins, R. Rosenfeld, E. Davy, K. Graham, F. Jacobsen, S. Stevenson, J. Ho, Q. Chen, T. Hartmann, M. Michaels, M. Kelley, L. Li, K. Sitney, F. Martin, J.-R. Sun, N. Zhang, J. Lu, J. Estrada, R. Kumar, A. Coxon, S. Kaufman, J. Pretorius, S. Scully, R. Cattley, M. Payton, S. Coats, L. Nguyen, B. Desilva, A. Ndifor, I. Hayward, R. Radinsky, T. Boone, R. Kendall, Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6, 507-516 (2004).
34. C. Daly, A. Eichten, C. Castanaro, E. Pasnikowski, A. Adler, A. S. Lalani, N. Papadopoulos, A. H. Kyle, A. I. Minchinton, G. D. Yancopoulos, G. Thurston, Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition. Cancer Res. 73, 108-118 (2013).
35. T. Holopainen, P. Saharinen, G. D'Amico, A. Lampinen, L. Eklund, R. Sormunen, A. Anisimov, G. Zarkada, M. Lohela, H. Heloterä, T. Tammela, L. E. Benjamin, S. Ylä-Herttuala, C. C. Leow, G. Y. Koh, K. Alitalo, Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl. Cancer Inst. 104, 461-475 (2012).
36. X. Zhang, L. Gan, H. Pan, S. Guo, X. He, S. T. Olson, A. Mesecar, S. Adam, T. G. Unterman, Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J. Biol. Chem. 277, 45276-45284 (2002).
37. K.-T. Kim, H.-H. Choi, M. O. Steinmetz, B. Maco, R. A. Kammerer, S. Y. Ahn, H.-Z. Kim, G. M. Lee, G. Y. Koh, Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. 280, 20126-20131 (2005).
38. G. Y. Koh, Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol. Med. 19, 31-39 (2013).
39. E. Bogdanovic, V. P. K. H. Nguyen, D. J. Dumont, Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J. Cell Sci. 119, 3551-3560 (2006).
40. D. Rittirsch, M. S. Huber-Lang, M. A. Flierl, P. A. Ward, Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4, 31-36 (2008).
41. S. D. McCarter, S. H. J. Mei, P. F. H. Lai, Q. W. Zhang, C. H. Parker, R. S. Suen, R. D. Hood, Y. D. Zhao, Y. Deng, R. N. Han, D. J. Dumont, D. J. Stewart, Cell-based angiopoietin-1 gene therapy for acute lung injury. Am. J. Respir. Crit. Care Med. 175, 1014-1026 (2007).
42. S. Weinbaum, J. M. Tarbell, E. R. Damiano, The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 9, 121-167 (2007).
43. E. P. Schmidt, Y. Yang, W. J. Janssen, A. Gandjeva, M. J. Perez, L. Barthel, R. L. Zemans, J. C. Bowman, D. E. Koyanagi, Z. X. Yunt, L. P. Smith, S. S. Cheng, K. H. Overdier, K. R. Thompson, M. W. Geraci, I. S. Douglas, D. B. Pearse, R. M. Tuder, The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. 18, 1217-1223 (2012).
44. A. H. J. Salmon, C. R. Neal, L. M. Sage, C. A. Glass, S. J. Harper, D. O. Bates, Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc. Res. 83, 24-33 (2009).
45. J. R. Tisoncik, M. J. Korth, C. P. Simmons, J. Farrar, T. R. Martin, M. G. Katze, Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76, 16-32 (2012).
46. P. Kümpers, M. van Meurs, S. David, G. Molema, J. Bijzet, A. Lukasz, F. Biertz, H. Haller, J. G. Zijlstra, Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit. Care 13, R64 (2009).
47. J. S. Davis, T. W. Yeo, K. A. Piera, T. Woodberry, D. S. Celermajer, D. P. Stephens, N. M. Anstey, Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit. Care 14, R89 (2010).
48. K. A. Shirey, W. Lai, A. J. Scott, M. Lipsky, P. Mistry, L. M. Pletneva, C. L. Karp, J. McAlees, T. L. Gioannini, J. Weiss, W. H. Chen, R. K. Ernst, D. P. Rossignol, F. Gusovsky, G. Blanco, S. N. Vogel, The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497, 498-502 (2013).
49. H. Wang, H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E. J. Miller, K. J. Tracey, L. Ulloa, Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221 (2004).
50. K. J. Tracey, Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, A. Cerami, Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664 (1987).
51. E. J. Kerschen, J. A. Fernandez, B. C. Cooley, X. V. Yang, R. Sood, L. O. Mosnier, F. J. Castellino, N. Mackman, J. H. Griffin, H. Weiler, Endotoxemia and sepsis mortality reduction by nonanticoagulant-activated protein C. J. Exp. Med. 204, 2439-2448 (2007).
52. J. H. Kang, M. Super, C. W. Yung, R. M. Cooper, K. Domansky, A. R. Graveline, T. Mammoto, J. B. Berthet, H. Tobin, M. J. Cartwright, A. L. Watters, M. Rottman, A. Waterhouse, A. Mammoto, N. Gamini, M. J. Rodas, A. Kole, A. Jiang, T. M. Valentin, A. Diaz, K. Takahashi, D. E. Ingber, An extracorporeal blood-cleansing device for sepsis therapy. Nat. Med. 20, 1211-1216 (2014).
53. W. A. Barton, D. Tzvetkova-Robev, E. P. Miranda, M. V. Kolev, K. R. Rajashankar, J. P. Himanen, D. B. Nikolov, Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat. Struct. Mol. Biol. 13, 524-532 (2006).
54. A. L. Rasmussen, A. Okumura, M. T. Ferris, R. Green, F. Feldmann, S. M. Kelly, D. P. Scott, D. Safronetz, E. Haddock, R. LaCasse, M. J. Thomas, P. Sova, V. S. Carter, J. M. Weiss, D. R. Miller, G. D. Shaw, M. J. Korth, M. T. Heise, R. S. Baric, F. P.-M. de Villena, H. Feldmann, M. G. Katze, Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 346, 987-991 (2014).
55. C. C. Ghosh, A. Mukherjee, S. David, U. G. Knaus, D. J. Stearns-Kurosawa, S. Kurosawa, S. M. Parikh, Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc. Natl. Acad. Sci. U. S. A. 109, 10024-10029 (2012).
56. J. Shen, M. Frye, B. L. Lee, J. L. Reinardy, J. M. McClung, K. Ding, M. Kojima, H. Xia, C. Seidel, R. Lima e Silva, A. Dong, S. F. Hackett, J. Wang, B. W. Howard, D. Vestweber, C. D. Kontos, K. G. Peters, P. A. Campochiaro, Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J. Clin. Invest. 124, 4564-4576 (2014).
57. G. T. Thurston, J. S. Rudge, E. Ioffe, H. Zhou, L. Ross, S. D. Croll, N. Glazer, J. Holash, D. M. McDonald, G. D. Yancopoulos, Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463 (2000).
58. M. G. Sugiyama, S. M. Armstrong, C. Wang, D. Hwang, H. Leong-Poi, A. Advani, S. Advani, H. Zhang, K. Szaszi, A. Tabuchi, W. M. Kuebler, P. Van Slyke, D. J. Dumont, W. L. Lee, The Tie2-agonist Vasculotide rescues mice from influenza virus infection. Sci. Rep. 5, 11030 (2015).
59. F. T. H. Wu, C. R. Lee, E. Bogdanovic, A. Prodeus, J. Gariépy, R. S. Kerbel, Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2. EMBO Mol. Med. 7, 770-787 (2015).
60. H. Y. Yang, K. J. Kang, J. E. Chung, H. Shim, Construction of a large synthetic human scFv library with six diversified CDRs and high functional diversity. Mol. Cells 27, 225-235 (2009).
61. G. Thurston, C. Daly, U. S. Patent 12/843, 905 (2010).
62. S.-J. Hwang, S. H. Kim, H.-Z. Kim, M. O. Steinmetz, G. Y. Koh, G. M. Lee, High-level expression and purification of a designed angiopoietin-1 chimeric protein, COMP-Ang1, produced in Chinese hamster ovary cells. Protein J. 27, 319-326 (2008).
63. Y. Arita, Y. Nakaoka, T. Matsunaga, H. Kidoya, K. Yamamizu, Y. Arima, T. Kataoka-Hashimoto, K. Ikeoka, T. Yasui, T. Masaki, K. Yamamoto, K. Higuchi, J.-S. Park, M. Shirai, K. Nishiyama, H. Yamagishi, K. Otsu, H. Kurihara, T. Minami, K. Yamauchi-Takihara, G. Y. Koh, N. Mochizuki, N. Takakura, Y. Sakata, J. K. Yamashita, I. Komuro, Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. Nat. Commun. 5, 4552 (2014).
64. B. Shen, Z. Shang, B. Wang, L. Zhang, F. Zhou, T. Li, M. Chu, H. Jiang, Y. Wang, T. Qiao, J. Zhang, W. Sun, X. Kong, Y. He, Genetic dissection of tie pathway in mouse lymphatic maturation and valve development. Arterioscler. Thromb. Vasc. Biol. 34, 1221-1230 (2014).
65. S. Savant, S. La Porta, A. Budnik, K. Busch, J. Hu, N. Tisch, C. Korn, A. F. Valls, A. V. Benest, D. Terhardt, X. Qu, R. H. Adams, H. S. Baldwin, C. Ruiz de Almodóvar, H.-R. Rodewald, H. G. Augustin, The orphan receptor Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells. Cell Rep. 12, 1761-1773 (2015).
66. M. R. Looney, E. E. Thornton, D. Sen, W. J. Lamm, R. W. Glenny, M. F. Krummel, Stabilized imaging of immune surveillance in the mouse lung. Nat. Methods 8, 91-96 (2011).
67. K. Choe, J. Y. Jang, I. Park, Y. Kim, S. Ahn, D.-Y. Park, Y.-K. Hong, K. Alitalo, G. Y. Koh, P. Kim, Intravital imaging of intestinal lacteals unveils lipid drainage through contractility. J. Clin. Invest. 125, 4042-4052 (2015).
68. A. Constantinescu, J. A. E. Spaan, E. K. Arkenbout, H. Vink, J. W. G. E. van Teeffelen, Degradation of the endothelial glycocalyx is associated with chylomicron leakage in mouse cremaster muscle microcirculation. Thromb. Haemost. 105, 790-801 (2011).
69. T. Itoh, H. Obata, S. Murakami, K. Hamada, K. Kangawa, H. Kimura, N. Nagaya, Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L446-L452 (2007).
70. M. J. Sung, D. H. Kim, Y. J. Jung, K. P. Kang, A. S. Lee, S. Lee, W. Kim, M. Davaatseren, J.-T. Hwang, H.-J. Kim, M. S. Kim, D. Y. Kwon, S. K. Park, Genistein protects the kidney from cisplatin-induced injury. Kidney Int. 74, 1538-1547 (2008).